Please use this identifier to cite or link to this item:
https://repository.iimb.ac.in/handle/2074/13048
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Krishnan, Rishikesha T | |
dc.date.accessioned | 2020-07-07T14:59:03Z | - |
dc.date.available | 2020-07-07T14:59:03Z | - |
dc.date.issued | 2013-01 | |
dc.identifier.uri | https://repository.iimb.ac.in/handle/2074/13048 | - |
dc.description | Management Next, January 2013 | |
dc.description.abstract | Stanford India Biodesign (SIB), the ambitious alliance between the Design School at Stanford, AIIMS and IIT Delhi to train a new generation of medical device innovators, is making steady progress. I attended the 6th Medtech Summit held at Delhi on December 21, 2012, and was impressed to see SIB on the verge of moving to Phase 2. I wrote about last year’s summit in an earlier blogpost, and it was good to see the visible progress over the last year. | |
dc.language.iso | en_US | |
dc.publisher | ManagementNext Media & Publications LLP | |
dc.subject | Innovation | |
dc.subject | medical device innovation | |
dc.subject | Medical technology | |
dc.subject | Biomedical engineering | |
dc.title | Stanford India biodesign makes a big impact | |
dc.type | Magazine and Newspaper Article | |
dc.journal.name | Management Next | |
Appears in Collections: | 2010-2019 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Krishnan_MGTNXT_2013_Jan_P.10-11.pdf | 92.65 kB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.